Curcuma longa, a powerhouse plant, is highly antiinflammatory, treating cardiovascular, metabolic, and rheumatic disorders. Turmeric oils (a leaf fraction) and curcuminoids make this "curry" ingredient an essential culinary/medicinal botanical.
This site is a resource for herbal practitioners, it includes editorial content, articles and an extensive searchable and hyperlinked herbal database on current herbal therapeutics. Herbalists who register can access our herbal database free of charge.
As a certification company, CL enables companies of all sizes to have their products tested for potential inclusion in its list of Approved Quality products and bear the CL Seal. CL has tested more than 1,800 products, representing over 350 different bran
Big Pharma is also showing interest for this emerging market and an example which illustrates this attention is the deal that Merck KGaA has just signed with Chi-Med under which the German drugmaker will develop new cancer treatments using traditional Chi
just as morphine is a natural plant product able to activate the µ-opioid receptor, salvinorin A is a natural plant product able to activate the KOR. The strongly psychotomimetic actions of salvinorin A suggest that the dynorphin/-opioid system may have
Comprehensive course to become a certified Ayurvedic practitioner; approved by International Academy of Ayurveda in Pune, India and International Holistic Health Institute in Bangalore, India. Overview of Ayurveda, Ayurvedic medicine, Ayurvedic herbs.
There is a growing amount of evidence-based research supporting various botanicals; and/or primary evidence comes from a long medicinal use. Evidence-based research may be limited, but we shouldn't ignore botanicals that have been used for 1000s of years,
Magnolia Extract is rich in the phytochemicals honokiol and magnolol. Honokiol has a long history of use in traditional Chinese formulas that relieve anxiety without leaving you feeling like you've been drugged. Magnolol exerts an antidepressant effect. A
Big Pharma is also showing interest for this emerging market and an example which illustrates this attention is the deal that Merck KGaA has just signed with Chi-Med under which the German drugmaker will develop new cancer treatments using traditional Chi